Abstract
No public abstract is available from the verified source records.
Open public full textRights: UNKNOWN · cc-by-nc-nd · Source: journal-auto-sync:external:CROSSREF_ISSN
Amy E. DeZern, Johannes B. Goll, Travis L. Jensen, Nancy K. Gillis, Gregory A. Abel, H. Joachim Deeg, Tareq Al Baghdadi, Jane Jijun Liu, Rami S. Komrokji, Rafael Bejar, R. Coleman Lindsley, Seth Sherman, Nancy DiFronzo, Mikkael A. Sekeres
Abstract
Rights: UNKNOWN · cc-by-nc-nd · Source: journal-auto-sync:external:CROSSREF_ISSN
Authors
No local reference links have been materialized yet.
No local citing links have been materialized yet.
The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms
10.1038/s41375-022-01613-1 · 2022
Assessing clonal haematopoiesis: clinical burdens and benefits of diagnosing myelodysplastic syndrome precursor states
10.1016/s2352-3026(19)30211-x · 2020
Relationship between clone metrics and clinical outcome in clonal cytopenia
10.1182/blood.2021011323 · 2021
High concordance of genomic and cytogenetic aberrations between peripheral blood and bone marrow in myelodysplastic syndrome (MDS)
10.1038/leu.2015.110 · 2015
Myeloid NGS analyses of paired samples from bone marrow and peripheral blood yield concordant results: a prospective cohort analysis of the AGMT Study Group
10.3390/cancers15082305 · 2023
Targeted deep sequencing of CD34+ cells from peripheral blood can reproduce bone marrow molecular profile in myelodysplastic syndromes
10.1002/ajh.25089 · 2018
Mutational landscape and response are conserved in peripheral blood of AML and MDS patients during decitabine therapy
10.1182/blood-2016-10-745273 · 2017
High prevalence of clonal hematopoiesis in the blood and bone marrow of healthy volunteers
10.1182/bloodadvances.2020001582 · 2020
Mutational analysis of hematologic neoplasms in 164 paired peripheral blood and bone marrow samples by next-generation sequencing
10.1182/bloodadvances.2020002306 · 2020
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
NCCN guidelines(R) insights: myelodysplastic syndromes, version 3.2022
10.6004/jnccn.2022.0009 · 2022
The National MDS Natural History Study: design of an integrated data and sample biorepository to promote research studies in myelodysplastic syndromes
10.1080/10428194.2019.1616186 · 2019
Failure to detect mutations in U2AF1 due to changes in the GRCh38 reference sequence
10.1016/j.jmoldx.2021.10.013 · 2022
Somalier: rapid relatedness estimation for cancer and germline studies using efficient genome sketches
10.1186/s13073-020-00761-2 · 2020
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
10.1182/blood-2015-03-631747 · 2015
Prediction of acute myeloid leukaemia risk in healthy individuals
10.1038/s41586-018-0317-6 · 2018
Health-related quality of life and vulnerability among people with myelodysplastic syndromes: a US National Study
10.1182/bloodadvances.2022009000 · 2023
Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults
10.1038/ncomms12484 · 2016
Age-related clonal hematopoiesis associated with adverse outcomes
10.1056/nejmoa1408617 · 2014
Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease
10.1056/nejmoa1701719 · 2017
Clonal hematopoiesis in human aging and disease
10.1126/science.aan4673 · 2019
Utility of targeted gene sequencing to differentiate myeloid malignancies from other cytopenic conditions
10.1182/bloodadvances.2022008578 · 2023
Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapies
10.1182/bloodadvances.2023010061 · 2023
CHIP, CCUS, and other acronyms: definition, implications, and impact on practice
10.1200/edbk_239083 · 2019
Parallel genomic analysis from paired bone marrow and peripheral blood samples of 200 cytopenic patients
2023
Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet
10.1182/blood-2013-03-492884 · 2013
Myelodysplastic syndromes, version 2.2017, NCCN clinical practice guidelines in oncology
10.6004/jnccn.2017.0007 · 2017
No additional external references are available.